1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR Inhibitors

CXCR Inhibitors

CXCR

CXCR1

CXCR2

CXCR3

CXCR4

CXCR7

CXCR6

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CXCR Inhibitors, Agonists, Antagonists & Modulators
Product Name CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CXCR6 Purity
Plerixafor        
125I-CXCL12-CXCR4, IC50: 44 nM
    ≥98.0%
SB225002    
125I-IL-8-CXCR2, IC50: 22 nM (in CHO cell membrane)
        99.87%
AMG 487      
125I-IP10-CXCR3, IC50: 8 nM
125I-ITAC-CXCR3, IC50: 8.2 nM
      99.65%
AZD8797    
125I-IL-8-CXCR2, Ki: 2800 nM (in HEK293S cells)
        98.73%
Reparixin  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
        99.98%
CXCR7 antagonist-1 hydrochloride          
CXCR7
 
ACT-660602      
CXCR3, IC50: 204 nM
     
Navarixin  
Cynomolgus CXCR1, Kd: 41 nM
125I-CXCL8-CXCR1, IC50: 43 nM
Mouse CXCR2, Kd: 0.2 nM
Rat CXCR2, Kd: 0.2 nM
Cynomolgus CXCR2, Kd: 0.08 nM
125I-CXCL8-CXCR2, IC50: 0.97 nM
        99.13%
AZD-5069    
125I-IL-8-CXCR2
        99.63%
Plerixafor octahydrochloride        
125I-CXCL12-CXCR4, IC50: 44 nM
    ≥98.0%
Motixafortide        
CXCR4, IC50: ~1 nM
    99.03%
SCH 546738      
Human CXCR3, Ki: 0.4 nM
      98.71%
TAK-779      
mCXCR3, IC50: 369 nM (in PBMCs)
      99.73%
NBI-74330      
[125I]CXCL10-CXCR3, Ki: 1.5 nM (in CXCR3-CHO cell membranes)
[125I]CXCL11-CXCR3, Ki: 3.2 nM (in CXCR3-CHO cell membranes)
      99.62%
NUCC-390 dihydrochloride        
CXCR4
    99.59%
Mavorixafor trihydrochloride        
125I-SDF-CXCR4, IC50: 13 nM
    98.69%
SX-682  
CXCR1
CXCR2
        98.64%
IT1t dihydrochloride        
CXCL12/CXCR4, IC50: 2.1 nM
    99.89%
Reparixin L-lysine salt  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
        99.93%
Baohuoside I        
CXCR4
    99.96%
LY2510924        
125I-SDF-1α-CXCR4, IC50: 79.7 pM
125I-SDF-1α-CXCR4, Ki: 49.5 pM
    99.73%
Balixafortide TFA        
CXCR4, IC50: <10 nM
    98.19%
PS372424 hydrochloride      
Human CXCR3
      98.07%
ML339            
CXCR6, IC50: 140 nM
99.49%
WZ811        
CXCR4, EC50: 0.3 nM
    ≥98.0%
Danirixin    
CXCL8-CXCR2, IC50: 12.5 nM
        98.45%
Burixafor hydrobromide        
CXCR4
    ≥98.0%
VUF11207 fumarate          
CXCR7, pKi: 8.1
  98.92%
TC14012        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
  99.43%
CXCR7 antagonist-1          
CXCR7
  99.97%
AMD 3465 hexahydrobromide        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
    ≥98.0%
FC131 TFA        
125I-SDF-1-CXCR4, IC50: 4.5 nM
    98.38%
CXCR7 modulator 2          
CXCR7, Ki: 13 nM
  98.39%
CXCR2-IN-1    
CXCR2, pIC50: 9.3
        99.47%
MSX-122        
CXCR4/CXCL12, IC50: ~10 nM
   
SB-265610    
CXCR2
        ≥99.0%
USL311        
CXCR4
    99.97%
ALX 40-4C Trifluoroacetate        
SDF-1-CXCR4, Ki: 1 μM
   
Nicotinamide N-oxide    
CXCR2
        99.85%
CXCR2-IN-2  
CXCR1, IC50: 3.8 μM
CXCR2, IC50: 5.2 nM
        98.45%
SRT3190    
CXCR2
        99.32%
Elubrixin tosylate    
CXCR2
        99.74%
UNBS5162
CXCL
            99.92%
Ladarixin sodium  
CXCR1
CXCR2
        99.15%
MSX-130        
CXCR4
    98.00%
SCH 563705  
CXCR1, Ki: 3 nM
CXCR1, IC50: 7.3 nM
CXCR2, Ki: 1 nM
CXCR2, IC50: 1.3 nM
Mouse CXCR2, IC50: 5.2 nM
        98.20%
CXCR7 modulator 1          
CXCR7, Ki: 9 nM
  99.67%
IT1t        
CXCL12/CXCR4, IC50: 2.1 nM
   
CTCE-9908        
CXCR4
    99.69%
ALX 40-4C        
SDF-1-CXCR4, Ki: 1 μM
   
NUCC-390        
CXCR4
   
PS372424      
Human CXCR3
     
Mavorixafor        
125I-SDF-CXCR4, IC50: 13 nM
   
KRH-3955 hydrochloride        
SDF-1α-CXCR4, IC50: 0.61 nM
   
AMG 487 (S-enantiomer)      
CXCR3
      98.92%
AMD 3465        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
   
SRT3109    
CXCR2, pIC50: 8.2
        99.82%
Balixafortide        
CXCR4, IC50: <10 nM
   
Elubrixin    
CXCR2
       
MSX-127        
CXCR4
   
CXCR4 antagonist 7        
CXCR4/CXCL12, IC50: 9.3 nM
   
CXCR2 antagonist 7    
CXCR2, IC50: 0.044 μM
       
CXCR2 antagonist 8    
CXCR2
       
CTCE-9908 TFA        
CXCR4
   
CXCR2 antagonist 6    
CXCR2, IC50: 0.43 μM
       
TC14012 TFA        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
 
CXCR2 antagonist 5    
CXCR2, IC50: 0.013 μM
       
CXCR4 modulator-1        
CXCR4, EC50: 100 nM
   
CXCR4 antagonist 5        
CXCR4, IC50: 8.8 nM
   
CXCR4 antagonist 9        
CXCR4, IC50: 15 nM
   
CXCR4 antagonist 3        
CXCR4, IC50: 11 nM
   
CXCR4 antagonist 4        
CXCR4, IC50: 24 nM
   
ATI-2341        
CXCR4, EC50: 194 nM (in CCRF-CEM cells)
   
CXCR4 modulator-2        
CXCR4, IC50: 1.25 nM
   
CXCR4 antagonist 8        
CXCR4, IC50: 57 nM
   
Corydalmine    
CXCR2
       
CXCR4 antagonist 1        
CXCR4
   
CTCE-0214        
SDF-1α-CXCR4
   
HF50731        
CXCR4, IC50: 19.8 nM
   
CXCR2 antagonist 4    
CXCR2, IC50: 0.13 μM
       
CXCR4 antagonist 6        
CXCR4, IC50: 79 nM
   
FC131        
125I-SDF-CXCR4, IC50: 4.5 nM